The ubiquitination of the influenza a virus PB1-F2 protein is crucial for its biological function

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Košík, Ivan ^a   Práznovská, Margaréta ^a   Košíková, Martina ^a   Bobišová, Zuzana ^a   Hollý, Jaroslav ^a   Varečková, Eva ^a   Kostolanský, František ^a   Russ, Gustáv ^a  

^a INSTITUTE OF VIROLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA INTERFERON; LYSINE; PB1-F2 PROTEIN; PROTEASOME; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; PB1-F2 PROTEIN, INFLUENZA A VIRUS; VIRAL PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CLUSTER; GENE DOSAGE; GENE MUTATION; GENETIC VARIABILITY; HALF LIFE TIME; HUMAN; HUMAN CELL; INFLUENZA A VIRUS (A/PUERTO RICO/8/1934(H1N1)); INFLUENZA A VIRUS A HONG KONG 156 1997 H5N1; INFLUENZA VIRUS A; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; SEQUENCE ALIGNMENT; T LYMPHOCYTE; UBIQUITINATION; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; FEMALE; IMMUNOLOGY; INFLUENZA A VIRUS; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE HOMOLOGY;

AVES; INFLUENZA A VIRUS; MAMMALIA;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY FORMATION; CELL LINE; FEMALE; HUMANS; INFLUENZA A VIRUS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE HOMOLOGY, AMINO ACID; UBIQUITINATION; VIRAL PROTEINS;

EID: 84927614829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118477     Document Type: Article

References (59)

1. de Wit E, Fouchier RA. Emerging influenza. J Clin Virol. 2008; 41(1):1-6. Epub 2008/03/15. PMID: 18340670
2. Muramoto Y, Noda T, Kawakami E, Akkina R, Kawaoka Y. Identification of novel influenza A virus proteins translated from PA mRNA. J Virol. 2013; 87(5):2455-62. Epub 2012/12/14. doi: 10.1128/JVI. 02656-12 JVI.02656-12 PMID: 23236060
3. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, et al. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med. 2001; 7(12):1306-12. Epub 2001/12/01. doi: 10.1038/ nm1201-1306nm1201-1306 PMID: 11726970
4. Kosik I, Krejnusova I, Bystricka M, Polakova K, Russ G. N-terminal region of the PB1-F2 protein is responsible for increased expression of influenza A viral protein PB1. Acta Virol. 2011; 55(1):45-53. Epub 2011/03/26. PMID: 21434704
5. Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S. The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol. 2008; 10(5):1140-52. Epub 2008/01/10. doi: 10.1111/j.1462-5822.2008.01116.xCMI1116 PMID: 18182088
6. McAuley JL, Zhang K, McCullers JA. The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol. 2010; 84(1):558-64. Epub 2009/10/16. doi: 10.1128/JVI.01785-09JVI.01785-09 PMID: 19828614
7. Marjuki H, Scholtissek C, Franks J, Negovetich NJ, Aldridge JR, Salomon R, et al. Three amino acid changes in PB1-F2 of highly pathogenic H5N1 avian influenza virus affect pathogenicity in mallard ducks. Arch Virol. 2010; 155(6):925-34. Epub 2010/04/13. doi: 10.1007/s00705-010-0666-4 PMID: 20383540
8. Chen CJ, Chen GW, Wang CH, Huang CH, Wang YC, Shih SR. Differential localization and function of PB1-F2 derived from different strains of influenza A virus. J Virol. 2010; 84(19):10051-62. Epub 2010/ 07/28. doi: 10.1128/JVI.00592-10JVI.00592-10 PMID: 20660199
9. Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW. The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol. 2003; 77(13):7214-24. Epub 2003/06/14. PMID: 12805420
10. Yamada H, Chounan R, Higashi Y, Kurihara N, Kido H. Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett. 2004; 578(3):331-6. Epub 2004/ 12/14. S0014-5793(04)01381-X [pii] doi: 10.1016/j.febslet.2004.11.017 PMID: 15589841
11. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 2005; 1(1):e4. Epub 2005/10/05. doi: 10.1371/journal.ppat.0010004 PMID: 16201016
12. Coleman JR. The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virology journal. 2007; 4:9. Epub 2007/01/17. 1743-422X-4-9 [pii] doi: 10.1186/1743-422X-4-9 PMID: 17224071
13. Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, Katze MG. A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol. 2011; 85(2):652-62. Epub 2010/11/19. doi: 10.1128/JVI.01987-10JVI.01987-10 PMID: 21084483
14. Alymova IV, Green AM, van de Velde N, McAuley JL, Boyd KL, Ghoneim HE, et al. Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82. J Virol. 2011; 85(23):12324-33. Epub 2011/09/23. doi: 10.1128/JVI.05872-11JVI.05872-11 PMID: 21937639
15. McAuley JL, Tate MD, MacKenzie-Kludas CJ, Pinar A, Zeng W, Stutz A, et al. Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease. PLoS Pathog. 2013; 9(5):e1003392. Epub 2013/06/06. doi: 10.1371/journal.ppat. 1003392PPATHOGENS-D-12-02482 PMID: 23737748
16. Dudek SE, Wixler L, Nordhoff C, Nordmann A, Anhlan D, Wixler V, et al. The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol Chem. 2011; 392(12):1135-44. Epub 2011/11/05. doi: 10.1515/BC.2011.174 PMID: 22050228
17. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, Fernandez-Sesma A, et al. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 2011; 7(6):e1002067. Epub 2011/06/23. doi: 10.1371/journal.ppat. 1002067PPATHOGENS-D-11-00235 PMID: 21695240
18. Varga ZT, Grant A, Manicassamy B, Palese P. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol. 2012; 86(16):8359-66. Epub 2012/06/08. doi: 10.1128/JVI.01122-12JVI.01122-12 PMID: 22674996
19. McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, McCullers JA. PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog. 2010; 6(7): e1001014. Epub 2010/07/28. doi: 10.1371/journal.ppat.1001014 PMID: 20661425
20. Alymova IV, Samarasinghe A, Vogel P, Green AM, Weinlich R, McCullers JA. A novel cytotoxic sequence contributes to influenza A viral protein PB1-F2 pathogenicity and predisposition to secondary bacterial infection. J Virol. 2014; 88(1):503-15. Epub 2013/11/01. doi: 10.1128/JVI.01373-13JVI. 01373-13 PMID: 24173220
21. Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol. 2006; 80(16):7976-83. Epub 2006/07/29. 80/16/7976 [pii] doi: 10.1128/JVI.00415-06 PMID: 16873254
22. ConenelloGM, Zamarin D, Perrone LA, Tumpey T, Palese P. A singlemutation in the PB1-F2 of H5N1 (HK/ 97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 2007; 3(10):1414-21.Epub 2007/10/10. 07-PLPA-RA-0345 [pii] doi: 10.1371/journal.ppat.0030141 PMID: 17922571
23. Le Goffic R, Leymarie O, Chevalier C, Rebours E, Da Costa B, Vidic J, et al. Transcriptomic analysis of host immune and cell death responses associated with the influenza A virus PB1-F2 protein. PLoS Pathog. 2011; 7(8):e1002202. Epub 2011/09/09. doi: 10.1371/journal.ppat.1002202PPATHOGENS-D-10-00445 PMID: 21901097
24. Krejnusova I, Gocnikova H, Bystricka M, Blaskovicova H, Polakova K, Yewdell J, et al. Antibodies to PB1-F2 protein are induced in response to influenza A virus infection. Arch Virol. 2009; 154(10):1599-604. Epub 2009/08/13. doi: 10.1007/s00705-009-0479-5 PMID: 19672555
25. Khurana S, Suguitan AL Jr., Rivera Y, Simmons CP, Lanzavecchia A, Sallusto F, et al. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med. 2009; 6(4):e1000049. Epub 2009/04/22. doi: 10.1371/ journal.pmed.1000049 PMID: 19381279
26. Kosik I, Krejnusova I, Praznovska M, Russ G. The multifaceted effect of PB1-F2 specific antibodies on influenza A virus infection. Virology. 2013; 447(1-2):1-8. Epub 2013/11/12. doi: 10.1016/j.virol.2013. 08.022S0042-6822(13)00495-9 PMID: 24210126
27. Buehler J, Navi D, Lorusso A, Vincent A, Lager K, Miller CL. Influenza A virus PB1-F2 protein expression is regulated in a strain-specific manner by sequences located downstream of the PB1-F2 initiation codon. J Virol. 2013; 87(19):10687 -99. Epub 2013/07/26. doi: 10.1128/JVI.01520-13JVI.01520-13 PMID: 23885074
28. Belicha-Villanueva A, Rodriguez-Madoz JR, Maamary J, Baum A, Bernal-Rubio D, Minguito de la Escalera M, et al. Recombinant influenza A viruses with enhanced levels of PB1 and PA viral protein expression. J Virol. 2012; 86(10):5926-30. Epub 2012/03/09. doi: 10.1128/JVI.06384-11JVI.06384-11 PMID: 22398284
29. Svastova E, Witarski W, Csaderova L, Kosik I, Skvarkova L, Hulikova A, et al. Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain. J Biol Chem. 2012; 287(5):3392-402. Epub 2011/12/16. doi: 10.1074/jbc.M111.286062M111. 286062 PMID: 22170054
30. Lecker SH, Goldberg AL, Mitch WE. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol. 2006; 17(7):1807-19. Epub 2006/06/02. ASN.2006010083 [pii] doi: 10.1681/ASN.2006010083 PMID: 16738015
31. Worthington ZE, Carbonetti NH. Evading the proteasome: absence of lysine residues contributes to pertussis toxin activity by evasion of proteasome degradation. Infect Immun. 2007; 75(6):2946-53. Epub 2007/04/11. IAI.02011-06 [pii] doi: 10.1128/IAI.02011-06 PMID: 17420233
32. Kravtsova-Ivantsiv Y, Ciechanover A. Non-canonical ubiquitin-based signals for proteasomal degradation. J Cell Sci. 2012;125(Pt 3):539-48. Epub 2012/03/06. doi: 10.1242/jcs.093567125/3/539
33. Liao TL, Wu CY, Su WC, Jeng KS, Lai MM. Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J. 2010; 29(22):3879-90. Epub 2010/10/07. doi: 10.1038/ emboj.2010.250emboj2010250 PMID: 20924359
34. Xia R, Jia H, Fan J, Liu Y, Jia J. USP8 promotes smoothened signaling by preventing its ubiquitination and changing its subcellular localization. PLoS Biol. 2012; 10(1):e1001238. Epub 2012/01/19. doi: 10. 1371/journal.pbio.1001238PBIOLOGY-D-11-00938 PMID: 22253573
35. Lee JC, Wang GX, Schickling O, Peter ME. Fusing DEDD with ubiquitin changes its intracellular localization and apoptotic potential. Apoptosis. 2005; 10(6):1483-95. Epub 2005/10/20. doi: 10.1007/ s10495-005-1833-z PMID: 16235027
36. Chen BB, Mallampalli RK. Masking of a nuclear signal motif bymonoubiquitination leads to mislocalization and degradation of the regulatory enzyme cytidylyltransferase. Mol Cell Biol. 2009; 29(11):3062-75. Epub 2009/04/01. doi: 10.1128/MCB.01824-08MCB.01824-08 PMID: 19332566
37. Wang YE, Park A, Lake M, Pentecost M, Torres B, Yun TE, et al. Ubiquitin-regulated nuclearcytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding. PLoS Pathog. 2010; 6(11):e1001186. Epub 2010/11/19. doi: 10.1371/journal.ppat.1001186 PMID: 21085610
38. Schmolke M, Manicassamy B, Pena L, Sutton T, Hai R, Varga ZT, et al. Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog. 2011; 7(8):e1002186. Epub 2011/08/20. doi: 10.1371/journal.ppat.1002186PPATHOGENS-D-11-00304 PMID: 21852950
39. Pancucharova H, Russ G. PB1-F2 gene in influenza a viruses of different hemagglutinin subtype. Acta Virol. 2006; 50(4):269- 72. Epub 2006/12/21. PMID: 17177613
40. Meunier I, von Messling V. PB1-F2 modulates early host responses but does not affect the pathogenesis of H1N1 seasonal influenza virus. J Virol. 2012; 86(8):4271-8. Epub 2012/02/10. doi: 10.1128/JVI. 07243-11JVI.07243-11 PMID: 22318139
41. Bhat KP, Truax AD, Greer SF. Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression. J Biol Chem. 2010; 285(34):25893-903. Epub 2010/06/12. doi: 10.1074/jbc.M110.127746M110. 127746 PMID: 20538595
42. de Juan-Sanz J, Nunez E, Lopez-Corcuera B, Aragon C. Constitutive Endocytosis and Turnover of the Neuronal Glycine Transporter GlyT2 Is Dependent on Ubiquitination of a C-Terminal Lysine Cluster. PLoS One. 2013; 8(3). ARTN e58863 doi: 10.1371/journal.pone.0058863
43. Sumita K, Yoshino H, Sasaki M, Majd N, Kahoud ER, Takahashi H, et al. Degradation of Activated K-Ras Orthologue via K-Ras-specific Lysine Residues Is Required for Cytokinesis. J Biol Chem. 2014; 289(7):3950-9. Epub 2013/12/18. doi: 10.1074/jbc.M113.531178M113.531178 PMID: 24338482
44. Kim Y, Deng Y, Philpott CC. GGA2-and ubiquitin-dependent trafficking of Arn1, the ferrichrome transporter of Saccharomyces cerevisiae. Molecular Biology of the Cell. 2007; 18(5):1790-802. doi: 10. 1091/mbc.E06-09-0861 PMID: 17344478
45. Trovato R, Mulloy JC, Johnson JM, Takemoto S, de Oliveira MP, Franchini G. A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stability. J Virol. 1999; 73(8):6460-7. Epub 1999/07/10. PMID: 10400740
46. Pena L, Vincent AL, Loving CL, Henningson JN, Lager KM, Lorusso A, et al. Restored PB1-F2 in the 2009 pandemic H1N1 influenza virus has minimal effects in swine. J Virol. 2012; 86(10):5523-32. Epub 2012/03/02. doi: 10.1128/JVI.00134-12JVI.00134-12 PMID: 22379102
47. Kosik I, Holly J, Russ G. PB1-F2 expedition from the whole protein through the domain to aa residue function. Acta Virol. 2013; 57(2):138-48. Epub 2013/04/23. PMID: 23600872
48. Delogu G, Howard A, Collins FM, Morris SL. DNA vaccination against tuberculosis: expression of a ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity. Infection and immunity. 2000; 68(6):3097-102. Epub 2000/05/19. PMID: 10816449
49. Rodriguez F, Zhang J, Whitton JL. DNA immunization: ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J Virol. 1997; 71(11):8497-503. Epub 1997/10/29. PMID: 9343207
50. Fu F, Li X, Lang Y, Yang Y, Tong G, Li G, et al. Co-expression of ubiquitin gene and capsid protein gene enhances the potency of DNA immunization of PCV2 in mice. Virology journal. 2011; 8:264. Epub 2011/06/01. doi: 10.1186/1743-422X-8-264 PMID: 21624113
51. Chen JH, Yu YS, Liu HH, Chen XH, Xi M, Zang GQ, et al. Ubiquitin conjugation of hepatitis B virus core antigen DNA vaccine leads to enhanced cell-mediated immune response in BALB/c mice. Hepatitis monthly. 2011; 11(8):620-8. Epub 2011/12/06. PMID: 22140385
52. Stanekova Z, Vareckova E. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Virology journal. 2010; 7:351. Epub 2010/12/02. doi: 10.1186/1743-422X-7-3511743-422X-7-351 PMID: 21118546
53. Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem. 2005; 280(7):5571-80. Epub 2004/12/08. M410592200 [pii] doi: 10.1074/jbc.M410592200 PMID: 15579900
54. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, et al. Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol. 2007; 178(6):3368-72. Epub 2007/03/07. 178/6/3368 [pii]. PMID: 17339430
55. Randall RE, Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol. 2008; 89(Pt 1):1-47. Epub 2007/12/20. 89/1/1 [pii] doi: 10.1099/vir.0.83391-0
56. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006; 311:17-58. Epub 2006/10/20. PMID: 17048704
57. Le Goffic R, Bouguyon E, Chevalier C, Vidic J, Da Costa B, Leymarie O, et al. Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells. J Immunol. 2010; 185(8):4812-23. Epub 2010/09/17. doi: 10.4049/jimmunol.0903952jimmunol.0903952 PMID: 20844191
58. Graef KM, Vreede FT, Lau YF, McCall AW, Carr SM, Subbarao K, et al. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. J Virol. 2010; 84(17):8433-45. Epub 2010/06/12. doi: 10.1128/JVI.00879-10JVI.00879-10 PMID: 20538852
59. Reis AL, McCauley JW. The influenza virus protein PB1-F2 interacts with IKKbeta and modulates NF-kappaB signalling. PLoS One. 2013; 8(5):e63852. Epub 2013/05/25. doi: 10.1371/journal.pone.0063852PONE-D-13-03319 PMID: 23704945